High Th1/Th2 ratio in patients with multiple myeloma-Reference-Cited by-同舟云学术

High Th1/Th2 ratio in patients with multiple myeloma

Published:2005-02 Issue:2 Volume:29 Page:135-140
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ogawara Hatsue,Handa Hiroshi,Yamazaki Tohru,Toda Takuma,Yoshida Kensuke,Nishimoto Natsumi,Al-ma’Quol Wedad Hamdi Saleh,Kaneko Yoriaki,Matsushima Takafumi,Tsukamoto Norifumi,Nojima Yoshihisa,Matsumoto Morio,Sawamura Morio,Murakami Hirokazu

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference21 articles.

1. The expanding universe of T-cell subsets: Th1, Th2 and more;Mosmann;Immunol. Today,1996

2. Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells;Nomura;Cytometry,2000

3. A clinical staging system for multiple myeloma;Durie;Cancer,1975

4. Lymphoid subsets and prognostic factor in multiple myeloma;San Miguel;Brit. J. Haematol.,1992

5. Relation between CD4+/CD8+ T cell ratio and T cell activation in multiple myeloma: reference to IL-6;Koike;Leukemia Res.,2002

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection‐related hospitalizations in multiple myeloma patients;Hematological Oncology;2023-05-25

2. Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma;Frontiers in Immunology;2023-04-12

3. Single‐cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage‐targeted strategy in multiple myeloma;British Journal of Haematology;2023-02-28

4. Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level;Blood Advances;2022-11-22

5. A Journey through the Inter-Cellular Interactions in the Bone Marrow in Multiple Myeloma: Implications for the Next Generation of Treatments;Cancers;2022-08-04